14 July 2014 by Marlene Rabinovitch

Harnessing Pathology of Pulmonary Hypertension to Therapeutic Advantage

All credits to Marlene Rabinovitch FPVRI, Professor of Pediatrics, at Stanford University School of Medicine, in Stanford- California | United States

Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA

 

Additional key-words:  endothelin receptor antagonists,BMPR2,PPARgamma,p53

Science that starts with a hello.

Through global collaboration, we make today's work, tomorrow's possibility.

Join the PVRI
standard-example-image.jpg